Look for:

Our offer for

ABIOMED INC.


ISIN:
US0036541003
WKN:
003654100

2022/07/01 22:00:00
Price
254.56 USD
Difference 2.85% (7.05)

General attributes

ISINUS0036541003
SymbolABMD
ExchangeNasdaq
CurrencyUSD
SectorOther
Security typeStock
Market cap (m)11,071 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)200.00 USD (100)
Ask (Ask size)350.00 USD (100)
Open246.42 USD
High254.82 USD
Low244.66 USD
Close (prev. day)247.51 USD
VWAP252.521653 USD
Volume (pcs)218,377
Trading volume54,962,823.26
Number of trades9,680
Last size31,449

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: ABIOMED INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/07/01 22:00:00
Price
254.56 USD
Difference 2.85% (7.05)

General attributes

ISINUS0036541003
SymbolABMD
ExchangeNasdaq
CurrencyUSD
SectorOther
Security typeStock
Market cap (m)11,071 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)200.00 USD (100)
Ask (Ask size)350.00 USD (100)
Open246.42 USD
High254.82 USD
Low244.66 USD
Close (prev. day)247.51 USD
VWAP252.521653 USD
Volume (pcs)218,377
Trading volume54,962,823.26
Number of trades9,680
Last size31,449

Performance and Risk

6m1Y3Y
Perf (%)-29.13%-18.65%-3.99%
Perf (abs.)-104.61-58.35-10.57
Beta1.671.570.86
Volatility55.6545.4148.30
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)252.48 USD (279,442)
Ø price 30 days | Ø volume 30 days (pcs.)249.95 USD (325,090)
Ø price 100 days | Ø volume 100 days (pcs.)283.56 USD (311,506)
Ø price 250 days | Ø volume 250 days (pcs.)313.67 USD (282,962)
YTD High | date368.97 USD (2022/01/04)
YTD Low | date219.85 USD (2022/06/16)
52 Weeks High | date379.30 USD (2021/11/10)
52 Weeks Low | date219.85 USD (2022/06/16)

All listings for ABIOMED INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2022/07/0122:26244.30 EUR0.013
Stuttgart2022/07/0108:02232.80 EUR0.003
Nasdaq2022/07/0122:00254.56 USD54.969,680
Munich2022/07/0108:00233.00 EUR0.001
London Stock Exchange2022/04/1214:47299.76 USD1.281
Hanover2022/07/0108:02233.90 EUR0.001
Frankfurt2022/07/0108:00233.90 EUR0.001
Duesseldorf2022/07/0119:30238.20 EUR0.009
Berlin2022/07/0108:08232.70 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=82282&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABIOMED INC.
- -
22 Cherry Hill Drive - 01923 Danvers
Telefon: 1-978-646-1400
Fax: 1-978-777-8411
E-mail: -

PDF Downloads

Company report: ABIOMED INC.PDF Download

Company Profile

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

Members of Management Board

Eric RoseMember of Board of Directors
Myron RolleMember of Board of Directors
Paula JohnsonMember of Board of Directors
William AustenMember of Board of Directors
Christopher van GorderMember of Board of Directors
Dorothy PuhyMember of Board of Directors
Jeannine RivetMember of Board of Directors
Martin SutterMember of Board of Directors
Paul ThomasMember of Board of Directors
Michael R. MinogueChairman of Managing Board
Thorsten SiessMember of Executive Committee
Andrew J. GreenfieldMember of Executive Committee
Chuck A. SimontonMember of Executive Committee
Karen MahoneyMember of Executive Committee
Laxmi PeriMember of Executive Committee
Marc BeganMember of Executive Committee
Matt PlanoMember of Executive Committee
Todd A. TrappMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer